176
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes

, &
Pages 245-251 | Published online: 24 Jun 2009

References

  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary DiseaseNHLBI/WHO workshop reportBethesdaNational Heart, Lung and Blood Institute42001 Update November 2006, GOLD website. Available at: www.goldcopd.com
  • ManninoDMHomaDMAkinbamiLJFordESReddSCChronic obstructive pulmonary disease surveillance – United States, 1971–2000MMWR200251116
  • MurrayCGLLopezADEvidence-based health policy-lessons from the global burden of disease studyScience19962747407438966556
  • FriedmanMWitekTJJrSerbyCWPharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared to ipratropium alone and albuterol alone in chronic obstructive pulmonary diseaseChest199911563564110084468
  • National Heart, Lung, and Blood InstituteMorbidity and Mortality: 2002 Chart Book on Cardiovascular, Lung, and Blood DiseasesBethesda, MdUS Department of Health and Human Services, Public Health Service, National Institutes of Health52002
  • FriedmanMHillemanDEEconomic burden of chronic obstructive pulmonary diseasePharmacoeconomics20011924525411303413
  • SeemungalTARDonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
  • KannerREAnthonisenNRConnettJEfor the Lung Health Study Research GroupLower respiratory illnesses promote FEV, decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116435836411500333
  • PlantPKOwenJLElliottMWNon-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcomeThorax20015670871211514692
  • ConnorsAFDawsonNVThomasCOutcomes following acute exacerbation of severe chronic obstructive lung diseaseAm J Respir Crit Care Med19961549599678887592
  • AlmagroPCalboEOchoa de EchaguenAMortality after hospitalization for COPDChest20021211441144812006426
  • Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSevere acute exacerbations amd mortality in patients with chronic obstructive pulmonary diseaseThorax20056092593116055622
  • MiravitllesMMurioCGuerreroTGisbertRon behalf of the DAFNE study groupPharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPDChest20021211449145512006427
  • JaeschkeRSingerJGuyattGHMeasurement of health status. Ascertaining the minimally clinically important differenceControl Clin Trials1989104074152691207
  • JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitationAm Rev Respir Dis1992145132113271595997
  • JonesPWInterpreting thresholds for a clinically significant change in health status in asthma and COPDEur Resp J200219398404
  • DisseBSpeckGARomingerKLWitekTJHammerRTiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung diseaseLife Sci19996445746410069510
  • CasaburiRMahlerDAJonesPWWannerASan PedroGZuWallackRLA long-term evaluation of once-daily tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921722411866001
  • VinckenWvan NoordJAGreefhorstAPMBantjeThAKestenSKorduckiLImproved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J20021920921611871363
  • BrusascoVHodderRMiravitllesMKorduckiLTowseLKestenSHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax20035839940412728159
  • O’DonnellDFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J20042383284015218994
  • MaltaisFHamiltonAMarciniukDImprovements in symptom-limited exercise performance over eight hours with once-daily tiotropium in patients with COPDChest20051281168117816162703
  • DusserDBravoMLIacono on behalf of the MISTRAL study groupThe effect of tiotropium on exacerbations and airflow in patients with COPDEur Resp J200627547555
  • NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergics bronchodilatorAnn Intern Med2005143319326
  • Standardization of spirometry – 1994 update: statement of the American Thoracic SocietyAm J Respir Crit Care Med1995152S77S1207582322
  • MahlerDAWeinbergDHWellsCKFeinsteinARThe measurement of dyspnea: contents, interobserver agreement and physiologic correlates of two new clinical indexesChest1984857517586723384
  • WitekTJMahlerDAMeaningful effect size and patterns of response of the transition dyspnea indexJ Clin Epidemiol200356324825512725879
  • WitekTJMahlerDAMinimal important difference of the transition dyspnoea index in a multinational clinical trialEur Respir J200321226727212608440
  • Rodriquez-RoisinRTowards a consensus definition for COPD exacerbationsChest2000117398S401S10843984
  • CelliBRMacNeeWcommittee membersStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Resp J200423932946
  • DonaldsonGCSeemungalTARBhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax20025784785212324669